Description
Patient diversity and representation in clinical trials have become a priority for stakeholders across the industry and for regulatory authorities around the world. Join the featured speakers as they discuss some of the factors underpinning the lack of patient diversity in clinical trials, investigate the implications this has for patients, and discuss what we can do to design more patient-centric and diverse clinical trials.